Nf. Vandet et al., EFFECTS OF HIGH GLUCOSE ON THE PRODUCTION OF HEPARAN-SULFATE PROTEOGLYCAN BY MESANGIAL AND EPITHELIAL-CELLS, Kidney international, 49(4), 1996, pp. 1079-1089
Changes in heparan sulfate metabolism may be important in the pathogen
esis of diabetic nephropathy. Recent studies performed on renal biopsi
es from patients with diabetic nephropathy revealed a decrease in hepa
ran sulfate glycosaminoglycan staining in the glomerular basement memb
rane without changes in staining for heparan sulfate proteoglycan-core
protein. To understand this phenomenon at the cellular level, we inve
stigated the effect of high glucose conditions on the synthesis of hep
aran sulfate proteoglycan by glomerular cells in vitro. Human adult me
sangial and glomerular visceral epithelial cells were cultured under n
ormal (5 mM) and high glucose (25 mM) conditions. Immunofluorescence p
erformed on cells cultured in 25 mM glucose confirmed and extended the
in vivo histological observations. Using metabolic labeling we observ
ed an altered proteoglycan production under high glucose conditions, w
ith predominantly a decrease in heparan sulfate compared to dermatan s
ulfate or chondroitin sulfate proteoglycan. N-sulfalion analysis of he
paran sulfate proteoglycan produced under high glucose conditions reve
aled less di- and tetrasaccharides compared to larger oligosaccharides
, indicating an altered sulfation pattern. Furthermore, with quantific
ation of glomerular basement membrane heparan sulfate by ELISA, a sign
ificant decrease was observed when mesangial and visceral epithelial c
ells were cultured in high glucose conditions. We conclude that high g
lucose concentration induces a significant alteration of heparan sulfa
te production by mesangial cells and visceral epithelial cells. Change
s in sulfation and changes in absolute quantities are both observed an
d may explain the earlier in vivo observations. These changes may be o
f importance for the altered integrity of the glomerular charge-depend
ent filtration barrier and growth-factor matrix interactions in diabet
ic nephropathy.